- Published at
- by investing.com
positive
positive
FDA grants Orphan Drug status to CervoMed's dementia drug By Investing.com
FDA grants Orphan Drug status to CervoMed's dementia drug
News for Diffusion Pharmaceuticals Inc. (DFFN)
- Published at
- by investing.com
positivepositiveCervoMed appoints new CFO ahead of clinical trial results By Investing.com
CervoMed appoints new CFO ahead of clinical trial results- Published at
- by prnewswire.com
positivepositiveCervoMed to Present at the 2023 Roth Healthcare Opportunities Conference
/PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced...- Published at
- by prnewswire.com
positivepositiveCervoMed Announces Publication in Neurology® Results Showing a Blood Test at Study Entry Identified Patients Who Demonstrated Substantial Response to Neflamapimod in Dementia with Lewy Bodies
/PRNewswire/ -- CervoMed Inc., a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced the...- Published at
- by seekingalpha.com
positivepositiveCervoMed shares soar following merger, reverse stock split (NASDAQ:CRVO)
Shares of CervoMed (CRVO) soared Thursday during their first day of trading in the wake of a merger between Diffusion Pharmaceuticals (DFFN) and EIP Pharma and a reverse stock split.- Published at
- by prnewswire.com
positivepositiveCervoMed Announces Completion of Merger with EIP Pharma
/PRNewswire/ -- CervoMed Inc. (formerly known as Diffusion Pharmaceuticals Inc.) (NASDAQ: CRVO), now a clinical-stage company focused on developing treatments...- Published at
- by globenewswire.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DFFN, TRTN, CNXC
NEW YORK, July 23, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by marketscreener.com
mixedmixedIMPORTANT ALERT: Halper Sadeh LLC Investigates CFMS, DFFN, ARNC, GRNA
NEW YORK, June 23, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: ...- Published at
- by globenewswire.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CIR, CTIC, DFFN
NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by marketscreener.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, RADI, BGRY, DFFN
NEW YORK, May 22, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches... | May 23, 2023- Published at
- by prnewswire.com
positivepositiveMoore Kuehn Encourages DFFN, KMF, CSTI, and BGRY Investors to Contact Law Firm
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...- Published at
- by rttnews.com
mixedmixed- Published at
- by etfdailynews.com
mixedmixedInvestment Analysts’ New Coverage for May 21st (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS)
Read Investment Analysts’ New Coverage for May 21st (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily NewsXELBWVVIWNEBWHLMVTVTULBIUBFOTTOOTTNPTSBKTRIBTRECTENXTEDUSYPRSVVCSUMRSTRMSREVSOHOSNFCASMMTSIEBSFESBFGSALRVSBRNWKRMTIRMCFRGLSRGCORDIRAVEQUMUQUIKPWODPWFLPULMPRPHPPBBPFIEPEBKPDEXPCTIPBPBOVLYOVBCOBCINYMXNWFLNVCNNTWKNTICNHNERVNEPTNAIIMUXMPXMCHXMBCNMACKLWAYLEDSLARKKTCCITCBITAUCORP.SNIRSA.BAIRSIRIXIPDNIHTIDRAHZNHWBKHLGHBPHALLGTIMGSITGNCAGIGMGHMGENCGASSFWPFUNCFSFGFORDFOEFNWBFENGFCCOFCAPFANHEVOKEVKESSAEMLEDUCEBMTDYNTDXYNDTEADFFNDCTHCYDCYCCCVVCVLYCTHRCPIXCORRCOECNETCMCMCLSNCLROCLRBCLIRCJJDCHNRCHMGCHCICGIXCFMSCFFICEMICDTXCBFVCAASBYFCBLPHBLCMBGSFBBGIAUTOASURASTCARLARKRAPAMSALOTALIMAKTXAIRIAGFSAEZSAEYAEMDACRXACORABEOAAMEAACGCGACFRX- Published at
- by benzinga.com
mixedmixedStocks That Hit 52-Week Lows On Monday
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was ...VMEOOSCRNATKPTIEFOIEARAXDXAGRXACXPACADWDHVECTTLSATLMDTLGTTARASDCSCPSSBBPRMTIQSPRLBPIXYPHGNVROMSGMMMATMDVLMDGLLTCHLMNLLIVKJUPWJRJCHOTHGANXFLXNEVFMEVERESGCEMELOXEHTHDMDGLYCTOSCRVSBXRXBQAXSMAVROATNXATHMARNAAPPHZIOPYYYSGYJVYNTVSTAVLDRTXMDTRKATMCITASTSPOTD.BASPOKSNTGSLQTSKLZSAMRMOREDURAASQTWOPTRAPSFEPOSHPHIOPALIOTICORTXNVTANKTRNEWMNSOMFMCWMCRBLZLOTZLIQTLGVNKURAKROSKPLTIOIMRAIMCRIKTIFRXHYMCHUYAHUIZHRTXHOOKHERAHARPHAPPGOGNPXGNCAGMTXGLTOFMCEYEGETONEPZMENVBDNMRDFFNDCPHCSPRCOECJJDCGRNCANGBZUNBMEABLSABLCTATXIATERATAIARDXARAVAKYAAKUAEI0UNL.L- Published at
- by pennystocks.com
mixedmixedTop Biotech Penny Stocks on Reddit? Check These 3 Out
3 Biotech Penny Stocks on Reddit to Watch in 2021 When creating a penny stocks watchlist we first need to consider what penny stocks are and the risk associate...- Published at
- by benzinga.com
positivepositiveDiffusion Pharmaceuticals Announces Full Exercise of Underwriter's Option to Purchase Additional Shares of Common Stock
CHARLOTTESVILLE, Va., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) ("Diffusion" or the "Company"), an innovative ...- Published at
- by benzinga.com
mixedmixedThe Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) 10X ...YMABUS87166B1026.SGTLISSYNHSNCASESNSEELPTGXPRTAPPDPCBK.MUPCBK.FPCBK.BEPAVMORMPNXEN.SGNXEN.FNXEN.BENKNG9.MUNG9.FNG9.BENEO.MXNEONARIMDTKRYSITCIIMUXHZNPHPR.MUHPR.FGTHXGNMKGMEDGM0N.FGM0N.BEG1H.FG1H.BEEXK.SGEXK.MUEXK.FEXK.BEEXASET82.SGET82.MUET82.FET82.DUET82.BEEPIXE031.FDRIODP81.SGDP81.FDP81.BEDMTKDFFNCTXRCBLIBP2M.FBP2M.BEBNTXN.MXBNTXAIKIAEZS.TOAEZSADAP8IN.MU8IN.F4KB.SG4KB.F4KB.BE47N.F473A.MU473A.F473A.BE2M6.MU2M6.F2M6.DE2M6.BE23I.MU23I.F23I.BE22UA.MU22UA.F22UA.DE22UA.BE1P5.SG1P5.F10VA.MU10VA.F10VA.BE0PT.FZEGA.SGZEGA.MUZEGA.FZEGA.BEZEG.SGZEG.MUZEG.FZEG.DEZEG.BEVKTXVCYTVARTXGTECHTE1.MUTE1.FTE1.BESXTCSWAVRPRXRPD.MURPD.FORMP.TAONCTOJU1.MUOJU1.FOJU1.BENVTA.MXNVTANVSN.MXNVSEFNVSNOVN.SWNOTA.MUNOTA.FNOTA.BENMTRMRK.PAMRK.MXMRKIV8.MUIV8.FIV8.BEIRWDINSPI76.FGXEA.FGXEA.BEGTU2.MUGTU2.FGLPGEVAXCTLTCLPTCERCC6K.FBPMCBNGO.MXBNGOBGNEBASIAZNN.MXAZNCFAZN.LAZNAVNSASLNANGNAMTIAGTC8HH.MU8HH.F8HH.BE7CB1.F7CB1.BE7A9.MU7A9.F7A9.BE6MK.MU6MK.F6MK.DE6MK.BE6160.HK49BA.SG36M.MU36M.F36M.BE2Y3.MU2Y3.BE2Q3.F2Q3.BE2L9.F2L9.BE2GT.MU2GT.F2GT.BE2DR.MU2DR.F2DR.BE1VT.MU1VT.F1VT.BE1KJ.MU1KJ.F1KJ.BE12V.F12V.BE0C8.MU0C8.F0C8.BEPFED.BAPFE.SGPFE.MXPFE.MUPFE.FPFE.DEPFE.BEPFEGENEDBTXBVSBLUEBLE.MUBLE.FAMGN.BAAMGNAMG.MUAMG.FAMG.DEAMG.BE- Published at
- by rttnews.com
mixedmixedBLUE Hit By SCD Trial Blues, CRTX Plunges On Partial Hold, SESN To Face FDA In August
Today's Daily Dose brings you news about temporary suspension of bluebird bio's gene therapy trials in sickle cell disease, Sesen Bio's regulatory catalyst for this year, partial hold on Cortexyme's open-label extension phase of its ongoing phase II/III study of Atuzaginstat for Alzheimer's disease, and expanded FDA approval of Novartis' Entresto.- Published at
- by markets.businessinsider.com
mixedmixedBLUE Hit By SCD Trial Blues, CRTX Plunges On Partial Hold, SESN To Face FDA In August
(RTTNews) - Today's Daily Dose brings you news about temporary suspension of bluebird bio's gene therapy trials in sickle cell disease, Sesen Bio'...- Published at
- by cnafinance.com
positivepositiveDFFN Stock: Diffusion Flies on COVID-19 News
DFFN stock is screaming for the top after the company announced positive data from its TSC candidate in COVID-19 patients.